- Rating
- 3(+1)
- Confidence
- 3
- Informativeness
- 2
- Presentation
- 1
- Soundness
- 2
Read review
Paper summary
The paper presents Minuet, a donor-aware integration method for single-cell multiomics data (scRNA-Seq and scATAC-Seq). The authors provide the theoretical foundations of the limitations of simple contrastive loss for the task, motivating the design of Minuet. Experiments are provided over a synthetic setting designed to challenge all identified weak spots as well as six different published datasets. The paper also provides thorough ablations of the method.
Critical strengths
-
The paper targets an important task — obtaining a shared donor multiome representation that is designed to transfer across donors
-
The overall framing is appealing — stemming from three concrete identified limitations of a standard contrastive approach, as motivation for concrete building blocks that are elegant and appealing.
Critical weaknesses
- Clarity and writing style.
The text is very dense in prose and leading claims rather than concrete descriptions and layout of intent. Many sentences and sections are very hard to follow. For example, section 5.4 “Ablations”, opens with “DC-PCA uses the target itself as the representation and ranks below MINUET” , the reader is expected to infer that this sentence, in the context of ablation, is there to justify that using only is not enough. Similarly, Section 3, which is meant to ground the theoretical motivation, uses narrative phrasing and subsection headers rather than directly enumerating and explaining the core leading theoretical limitation of standard contrastive learning.
- Presentation of the results.
Although Minuet demonstrates strong empirical performance overall, several evaluations and presentation choices could be better justified. While the authors follow the “scMultiBench benchmark”, the paper presents evaluation over a subset of benchmark metrics, and the main text focuses on ranking, rather than numerical results. The lack of the latter hides similarities in performance across compared methods over many metrics (details can be recovered through tables 6-16) .
Questions for authors
-
Can the authors provide a concise numerical presentation of the main results (including average and variations) and discuss them in detail.
-
Can the author explain the choice of the subset of scMultiBench metrics ?
-
Are the authors willing to commit to rewriting the paper, ensuring that they present the main concepts in a straightforward manner? (Without this, it is unlikely this paper meets the threshold for acceptance)
-
It will be interesting if the authors would comment on the broader implications of the work, including potential applications of the approach to other modalities or domains.
6 comments
(continued)
Q4. Broader implications.
The problem is not unique to multiome data. It arises whenever paired views are grouped by both technical and biological factors: CITE-seq or spatial data across donors, histology and expression across hospitals, or images and text across sites. In each case, contrastive learning allows each group to retain its own coordinates. The solution is the same: use a shared target to establish a common frame, and a penalty that preserves the group differences that matter.
The question we find most exciting comes next. Minuet uses recorded covariates to decide which donor differences to preserve, but for an individual, we often know much more—including their genome. Genetic variants are fixed at conception, so a cell-state difference associated with a variant reflects biology, not batch; we can estimate its effect on disease using Mendelian randomization. The rotated program in our toy represents such a variant. We plan to use genotypes to determine which donor differences the penalty should preserve, then ask which cell states a variant changes and whether those changes cause disease. Population-scale single-cell cohorts such as OneK1K make this feasible.
W1 / Q3. Clarity, and the commitment to rewrite. Thank you for making the changes; Section 3 indeed reads much better now! If possible, it will be great to use the additional page allowed in revisions to (1) extend the presentation / explanation of the results; and (2) write the discussion more directly in general.
W2 / Q1 / Q2. Numbers instead of ranks, and the choice of metrics. Thank you for making the changes in text and clarifying some of the choices here. The choice seems reasonable; however, the response above is a bit cryptically written and it is not very clear what the authors are trying to explain. (e.g. the sudden "jump" to "The donor-mixing choice matters most when some donors are sick..[]" ).
Related to the evaluations, the synthetic experiment now considers a different setting, focusing on cross-donor alignment. It no longer tests all three failure modes or compares against all baselines (it only includes contrastive controls and PCA, which already performs quite well). The experiment is designed to favor the PCA-based target, and PCA indeed performs quite well. Could the authors explain why the published baselines were not included in the new experiment setting?
Q4. Broader implications. Thank you for the clarification. It will be nice to add this to the discussion.
======== Q4. Broader implications.
The problem is not unique to multiome data. It arises whenever paired views are grouped by both technical and biological factors: CITE-seq or spatial data across donors, histology and expression across hospitals, or images and text across sites. In each case, contrastive learning allows each group to retain its own coordinates. The solution is the same: use a shared target to establish a common frame, and a penalty that preserves the group differences that matter.
The question we find most exciting comes next. Minuet uses recorded covariates to decide which donor differences to preserve, but for an individual, we often know much more—including their genome. Genetic variants are fixed at conception, so a cell-state difference associated with a variant reflects biology, not batch; we can estimate its effect on disease using Mendelian randomization. The rotated program in our toy represents such a variant. We plan to use genotypes to determine which donor differences the penalty should preserve, then ask which cell states a variant changes and whether those changes cause disease. Population-scale single-cell cohorts such as OneK1K make this feasible.
Thank you for the careful reading and the direct advice.
W1 / Q3. Clarity, and the commitment to rewrite.
Yes. We had started rewriting the paper after submission for the same reason you give, and your review pushed us further. In the main text of the revised PDF, red marks text we changed after submission, before the reviews arrived, and blue marks text we changed in response to the reviews.
Section 3 now starts by listing the three problems and the part of Minuet that fixes each one:
"When cells come from many donors, contrastive learning on paired cells has three problems. (i) Negatives from all donors reward encoding the donor (Eq. 2). (ii) Negatives from the same donor leave each donor free to rotate and shift its representation (Proposition 3.1). (iii) Removing all donor information also removes biology that differs between donors (Eq. 7). Minuet draws negatives within each donor to avoid (i), adds a shared prediction head that removes the rotations in (ii), and penalizes donor information only within covariate groups, which aligns the shifts while avoiding (iii)."
Section 4.4 now states what each ablation tests before presenting the result. The sentence you quote is gone. For example, the paragraph on the head now reads:
"Within-donor negatives alone do not transfer well. Adding the head and the penalty raises F1 on every cohort, and Table 1b shows that the head gives most of this gain. To see whether the head only reads out what the encoder already has, we freeze each encoder and fit the best linear head on top. On query donors, this head explains 34% of the target when the encoder was trained with the shared head and 20% when it was not. By Proposition A.2, a linear head cannot change what a linear readout sees, so the gain comes from the encoder."
If any part is still hard to follow, please tell us, and we will revise it.
W2 / Q1 / Q2. Numbers instead of ranks, and the choice of metrics.
We agree that the rank bubbles were hard to read. A rank tells you which method is better, but not by how much. The main figure now shows the scores themselves as bars, and Appendix C shows the same plots for each cohort, with error bars over three seeds.
Regarding the metrics, scMultiBench [1] includes many, several of which measure the same thing. For each question, we kept one or two in the main text and moved the others to the appendix.
The donor-mixing choice matters most when some donors are sick, and others are healthy. ROSMAP is a good example:
Apollo and MultiVI look the best mixed, but they predict Alzheimer status worse than random guessing. We think they look well mixed mostly because the disease signal is gone.
Minuet is not the best everywhere. IndiSeek, for example, transfers cell types to new donors better, but it hardly matches the RNA and ATAC profiles of the same cell, so its FOSCTTM is close to random. Section 4.3 now says this. Does this choice of metrics seem reasonable?
[1] Liu C, Ding S, Kim HJ, et al. Multitask benchmarking of single-cell multimodal omics integration methods. Nature Methods, 2025.
[2] Rautenstrauch P, Ohler U. Shortcomings of silhouette in single-cell integration benchmarking. Nature Biotechnology, 2026.
(continued in the next comment)